Quadrant Capital Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,340
| Closed | -$14.8K | – | 2561 |
|
|
2025
Q1 | $14.8K | Buy |
1,340
+1,314
| +5,054% | +$14.5K | ﹤0.01% | 2125 |
|
|
2024
Q4 | $277 | Hold |
26
| – | – | ﹤0.01% | 2687 |
|
|
2024
Q3 | $331 | Hold |
26
| – | – | ﹤0.01% | 2682 |
|
|
2024
Q2 | $437 | Hold |
26
| – | – | ﹤0.01% | 2637 |
|
|
2024
Q1 | $390 | Sell |
26
-30
| -54% | -$450 | ﹤0.01% | 2657 |
|
|
2023
Q4 | $840 | Hold |
56
| – | – | ﹤0.01% | 2571 |
|
|
2023
Q3 | $785 | Hold |
56
| – | – | ﹤0.01% | 2518 |
|
|
2023
Q2 | $580 | Hold |
56
| – | – | ﹤0.01% | 2555 |
|
|
2023
Q1 | $518 | Sell |
56
-41
| -42% | -$379 | ﹤0.01% | 2603 |
|
|
2022
Q4 | $860 | Hold |
97
| – | – | ﹤0.01% | 2569 |
|
|
2022
Q3 | $1K | Sell |
97
-104
| -52% | -$1.07K | ﹤0.01% | 2577 |
|
|
2022
Q2 | $2K | Sell |
201
-154
| -43% | -$1.53K | ﹤0.01% | 2285 |
|
|
2022
Q1 | $3K | Buy |
+355
| New | +$3K | ﹤0.01% | 2097 |
|
|
2021
Q4 | – | Sell |
-1,065
| Closed | -$18K | – | 2704 |
|
|
2021
Q3 | $18K | Buy |
1,065
+1,020
| +2,267% | +$17.2K | ﹤0.01% | 1306 |
|
|
2021
Q2 | $1K | Sell |
45
-16
| -26% | -$356 | ﹤0.01% | 2334 |
|
|
2021
Q1 | $1K | Hold |
61
| – | – | ﹤0.01% | 2307 |
|
|
2020
Q4 | $1K | Buy |
61
+46
| +307% | +$754 | ﹤0.01% | 2204 |
|
|
2020
Q3 | $0 | Buy |
+15
| New | – | ﹤0.01% | 2313 |
|